Skip to main content

Table 1 Baseline Characteristics of the Study Population

From: The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel

Age

(years)

62 ± 8.5

Male

(%)

79

Caucasian

(%)

100

SBP

(mmHg)

138.2 ± 18.6

DBP

(mmHg)

82.1 ± 9.2

Pulse

(beats/min)

61.7 ± 9.3

BMI

(kg/m2)

27.2 ± 3.7

Current smoking

(%)

16

History of hypertension

(%)

58

Diabetes mellitus

(%)

11

Previous PCI

(%)

38

Previous MI

(%)

37

Previous CABG

(%)

19

Total cholesterol

(mmol/L)

4.36 ± 0.94

LDL-cholesterol

(mmol/L)

2.38 ± 0.83

HDL-cholesterol

(mmol/L)

1.34 ± 0.36

Triglycerides

(mmol/L)

1.51 ± 1.12

Medication:

  

Aspirin

(%)

100

Clopidogrel

(%)

0

Statins

(%)

98

Betablockers

(%)

71

CCBs

(%)

23

PPIs

(%)

14

  1. Demographic and clinical characteristics of the study population (n = 219). Mean values ±SD and proportions are given.
  2. Abbreviations: SBP (systolic blood pressure), DBP (diastolic blood pressure), BMI (body mass index), PCI (percutaneous coronary intervention), MI (myocardial infarction), CABG (coronary arterial by-pass grafting), CCBs (Calcium Channel Blockers), PPIs (proton-pump inhibitors)
Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us